tirzepatide sleep apnea FDA Approves First Drug Breakthrough Treatment for Obstructive Sleep

Several are now underway including the REMODEL T1D trial (semaglutide and kidney disease in T1D) and the SURPASS-T1D phase 3 trials (tirzepatide in T1D) with results expected in the coming years

GLP-1 medications slow gastric emptying, allowing intestinal bacteria more time to ferment food and produce gas Gas, bloating, and flatulence are classified as common side effects, though frequency varies between products and individuals Symptoms typically emerge during initial treatment or dose escalation and often improve as the body adapts Dietary modifications, smaller meals, and gradual fibre adjustment can help manage gastrointestinal symptoms Severe abdominal pain, persistent vomiting, or signs of pancreatitis or gallbladder disease require prompt medical attention Table of Contents What Are GLP-1 Medications and How Do They Work

Group leader prof

Physician 43, 4651

A healthcare provider will decide if this is appropriate based on the patients condition and response to treatment